Yahoo
    Swiss - Delayed Quote CHF

    Sandoz Group AG (SDZ.SW)

    79.88 -2.22 (-2.70%)
    At close: 5:30:07 PM GMT+1
    SDZ.SW Q3 2026 earnings call
    Replay the call for the latest insights.
    Read transcript
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for SDZ.SW
    • Previous Close 82.10
    • Open 76.36
    • Bid 79.86 x --
    • Ask 79.88 x --
    • Day's Range 75.50 - 81.38
    • 52 Week Range 48.15 - 83.38
    • Volume 2,555,651
    • Avg. Volume 1,265,328
    • Market Cap (intraday) 34.563B
    • Beta (5Y Monthly) 0.46
    • PE Ratio (TTM) 68.27
    • EPS (TTM) 1.17
    • Earnings Date Aug 5, 2026
    • Forward Dividend & Yield 0.80 (0.97%)
    • Ex-Dividend Date Apr 13, 2026
    • 1y Target Est 78.71

    Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.

    www.sandoz.com

    20,000

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Sandoz Group AG

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

    YTD Return

    SDZ.SW
    39.78%
    MSCI WORLD (^990100-USD-STRD)
    10.76%

    1-Year Return

    SDZ.SW
    61.19%
    MSCI WORLD (^990100-USD-STRD)
    11.75%

    3-Year Return

    SDZ.SW
    242.45%
    MSCI WORLD (^990100-USD-STRD)
    80.74%

    5-Year Return

    SDZ.SW
    170.78%
    MSCI WORLD (^990100-USD-STRD)
    56.65%

    Earnings Trends

    View More

    Earnings Per Share

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q2 FY26
    Revenue 3B
    Earnings --
    Profit Margin 0.00%

    Q2

    FY25

    Q3

    FY25

    Q4

    FY25

    Q2

    FY26

    0
    1B
    2B
    3B
    0.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    59.84 Low
    78.71 Average
    79.88 Current
    108.85 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual
    As of 10/26/2026

    • Market Cap

      35.64B

    • Enterprise Value

      39.53B

    • Trailing P/E

      70.60

    • Forward P/E

      21.38

    • PEG Ratio (current)

      34.72

    • Price/Sales (ttm)

      3.89

    • Price/Book (mrq)

      4.90

    • Enterprise Value/Revenue

      4.27

    • Enterprise Value/EBITDA

      31.13

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      5.53%

    • Return on Assets (ttm)

      3.05%

    • Return on Equity (ttm)

      7.25%

    • Revenue (ttm)

      11.68B

    • Net Income Avi to Common (ttm)

      646M

    • Diluted EPS (ttm)

      1.17

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      2.27B

    • Total Debt/Equity (mrq)

      68.92%

    • Levered Free Cash Flow (ttm)

      1.37B

    View More

    Compare

    Compare

    Select to analyze similar companies using key performance metrics; select up to 4 stocks.

    SDZ.SW
    Sandoz Group AG
    79.88
    -2.70%
    Mkt Cap CHF 34.563B
    Industry Drug Manufacturers—Specialty & Generic
    GALD.SW
    Galderma Group AG
    185.20
    +0.11%
    Mkt Cap CHF 43.187B
    Industry Drug Manufacturers—Specialty & Generic
    SFZN.SW
    Siegfried Holding AG
    72.30
    -3.66%
    Mkt Cap CHF 3.167B
    Industry Drug Manufacturers—Specialty & Generic
    HIKl.XC
    Mkt Cap undefined -
    Industry -
    PPGN.SW
    PolyPeptide Group AG
    43.70
    -0.23%
    Mkt Cap CHF 1.443B
    Industry Drug Manufacturers—Specialty & Generic
    GALDz.XC
    Mkt Cap undefined -
    Industry -
    EAPI.PA
    Euroapi S.A.
    0.8040
    +0.37%
    Mkt Cap EUR 76.805M
    Industry Drug Manufacturers—Specialty & Generic
    1681.HK
    Consun Pharmaceutical Group Limited
    15.200
    -2.75%
    Mkt Cap HKD 12.735B
    Industry Drug Manufacturers—Specialty & Generic
    ALM.MC
    Almirall, S.A.
    10.42
    -0.19%
    Mkt Cap EUR 2.267B
    Industry Drug Manufacturers—Specialty & Generic
    ALVO
    Alvotech
    4.9500
    +4.21%
    Mkt Cap 1.766B
    Industry Drug Manufacturers—Specialty & Generic
    MRK.DE
    Merck KGaA
    146.05
    +1.07%
    Mkt Cap EUR 63.499B
    Industry Drug Manufacturers—Specialty & Generic

    People Also Watch

    NOVN.SW Novartis AG
    129.22 +0.34%
    ALC.SW Alcon Inc.
    57.64 +0.10%
    HOLN.SW Holcim AG
    68.10 +0.06%
    ACLN.SW Accelleron Industries AG
    67.30 +2.83%
    SLHN.SW Swiss Life Holding AG
    952.40 +1.06%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: